Brief: Tenax Therapeutics Inc - Received A Notice Of Allowance From Uspto For Its Patent Application With Claims Covering Use Of Tnx-103, Oral Levosimendan
31/05/2023 14:09
May 31 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS INC - RECEIVED A NOTICE OF ALLOWANCE
FROM
USPTO FOR ITS PATENT APPLICATION WITH CLAIMS COVERING USE OF
TNX-103, ORAL LEVOSIMENDAN
* TENAX THERAPEUTICS INC - INTENDS TO INITIATE A PHASE 3
TRIAL
USING ORAL FORMULATION OF LEVOSIMENDAN IN 2023
Source text for Eikon: ID:nGNX47S4Hl
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))